300 related articles for article (PubMed ID: 36165773)
21. Co-Occurrence of Multidrug Resistant Klebsiella pneumoniae Pathogenic Clones of Human Relevance in an Equine Pneumonia Case.
Venturini C; Bowring B; Partridge SR; Ben Zakour NL; Fajardo-Lubian A; Lopez Ayala A; Qin J; Totsika M; van Galen G; Norris J; Iredell J
Microbiol Spectr; 2022 Jun; 10(3):e0215821. PubMed ID: 35579468
[TBL] [Abstract][Full Text] [Related]
22. Phage therapy of antibiotic-resistant strains of Klebsiella pneumoniae, opportunities and challenges from the past to the future.
Mohammadi M; Saffari M; Siadat SD
Folia Microbiol (Praha); 2023 Jun; 68(3):357-368. PubMed ID: 37036571
[TBL] [Abstract][Full Text] [Related]
23. Bacteriophage in the treatment of experimental septicemic mice from a clinical isolate of multidrug resistant Klebsiella pneumoniae.
Vinodkumar CS; Neelagund YF; Kalsurmath S
J Commun Dis; 2005 Mar; 37(1):18-29. PubMed ID: 16637396
[TBL] [Abstract][Full Text] [Related]
24. Isolation and Characterization of Two
Domingo-Calap P; Beamud B; Mora-Quilis L; González-Candelas F; Sanjuán R
Int J Mol Sci; 2020 Apr; 21(9):. PubMed ID: 32365770
[TBL] [Abstract][Full Text] [Related]
25. Effect of Klebsiella-specific phage on multidrug-resistant Klebsiella pneumoniae- an experimental study.
Shree S; Suman E; Kotian H; Paul SH; M SS
Indian J Med Microbiol; 2024; 47():100515. PubMed ID: 37981030
[TBL] [Abstract][Full Text] [Related]
26. Fighting MDR-
Poerio N; Olimpieri T; Henrici De Angelis L; De Santis F; Thaller MC; D'Andrea MM; Fraziano M
Front Immunol; 2022; 13():835417. PubMed ID: 35237274
[No Abstract] [Full Text] [Related]
27. Genetic and Phenotypic Characterization of Multidrug-Resistant Klebsiella pneumoniae from Liver Abscess.
Qian C; Zhang S; Xu M; Zeng W; Chen L; Zhao Y; Zhou C; Zhang Y; Cao J; Zhou T
Microbiol Spectr; 2023 Feb; 11(1):e0224022. PubMed ID: 36598251
[TBL] [Abstract][Full Text] [Related]
28. Characterization of 29 newly isolated bacteriophages as a potential therapeutic agent against IMP-6-producing
Kondo K; Nakano S; Hisatsune J; Sugawara Y; Kataoka M; Kayama S; Sugai M; Kawano M
Microbiol Spectr; 2023 Sep; 11(5):e0476122. PubMed ID: 37724861
[TBL] [Abstract][Full Text] [Related]
29. Evaluation of the therapeutic effect of a novel bacteriophage in the healing process of infected wounds with Klebsiella pneumoniae in mice.
Kelishomi FZ; Nikkhahi F; Amereh S; Ghayyaz F; Marashi SMA; Javadi A; Shahbazi G; Khakpour M
J Glob Antimicrob Resist; 2024 Mar; 36():371-378. PubMed ID: 38307250
[TBL] [Abstract][Full Text] [Related]
30. Outbreak of Klebsiella pneumoniae ST11 Resistant To Ceftazidime-Avibactam Producing KPC-31 and the Novel Variant KPC-115 during COVID-19 Pandemic in Argentina.
Nicola F; Cejas D; González-Espinosa F; Relloso S; Herrera F; Bonvehí P; Smayevsky J; Figueroa-Espinosa R; Gutkind G; Radice M
Microbiol Spectr; 2022 Dec; 10(6):e0373322. PubMed ID: 36445147
[TBL] [Abstract][Full Text] [Related]
31. A fatal outbreak of ST11 carbapenem-resistant hypervirulent Klebsiella pneumoniae in a Chinese hospital: a molecular epidemiological study.
Gu D; Dong N; Zheng Z; Lin D; Huang M; Wang L; Chan EW; Shu L; Yu J; Zhang R; Chen S
Lancet Infect Dis; 2018 Jan; 18(1):37-46. PubMed ID: 28864030
[TBL] [Abstract][Full Text] [Related]
32. Designing phage cocktails to combat the emergence of bacteriophage-resistant mutants in multidrug-resistant
Yoo S; Lee K-M; Kim N; Vu TN; Abadie R; Yong D
Microbiol Spectr; 2024 Jan; 12(1):e0125823. PubMed ID: 38018985
[TBL] [Abstract][Full Text] [Related]
33. Safety and efficacy of a phage cocktail on murine wound infections caused by carbapenem-resistant Klebsiella pneumoniae.
Feng Y; Fang Q; Luo H; Li J; Yin X; Zong Z
Int J Antimicrob Agents; 2024 Feb; 63(2):107088. PubMed ID: 38218324
[TBL] [Abstract][Full Text] [Related]
34. Isolation and Molecular Characterization of a Novel Lytic Bacteriophage That Inactivates MDR
Balcão VM; Moreli FC; Silva EC; Belline BG; Martins LF; Rossi FPN; Pereira C; Vila MMDC; da Silva AM
Pharmaceutics; 2022 Jul; 14(7):. PubMed ID: 35890314
[TBL] [Abstract][Full Text] [Related]
35. Biological characteristics and genome analysis of a novel phage vB_KpnP_IME279 infecting Klebsiella pneumoniae.
Zhang R; Zhao F; Wang J; Pei G; Fan H; Zhangxiang L; Mi Z; Shi T; Liu H; Tong Y
Folia Microbiol (Praha); 2020 Dec; 65(6):925-936. PubMed ID: 33064268
[TBL] [Abstract][Full Text] [Related]
36. Characterization and comprehensive genome analysis of novel bacteriophage, vB_Kpn_ZCKp20p, with lytic and anti-biofilm potential against clinical multidrug-resistant
Zaki BM; Fahmy NA; Aziz RK; Samir R; El-Shibiny A
Front Cell Infect Microbiol; 2023; 13():1077995. PubMed ID: 36756618
[TBL] [Abstract][Full Text] [Related]
37. Characterization and genomic analysis of novel bacteriophage NK20 to revert colistin resistance and combat pandrug-resistant Klebsiella pneumoniae in a rat respiratory infection model.
Al-Madboly LA; Abdelaziz AA; Abo-Kamer AM; Nosair AM; Abdelkader K
Life Sci; 2023 Jun; 322():121639. PubMed ID: 37001805
[TBL] [Abstract][Full Text] [Related]
38. Cystatins 9 and C as a Novel Immunotherapy Treatment That Protects against Multidrug-Resistant New Delhi Metallo-Beta-Lactamase-1-Producing Klebsiella pneumoniae.
Holloway AJ; Yu J; Arulanandam BP; Hoskinson SM; Eaves-Pyles T
Antimicrob Agents Chemother; 2018 Mar; 62(3):. PubMed ID: 29229643
[TBL] [Abstract][Full Text] [Related]
39. Development of phage resistance in multidrug-resistant Klebsiella pneumoniae is associated with reduced virulence: a case report of a personalised phage therapy.
Li J; Yan B; He B; Li L; Zhou X; Wu N; Wang Q; Guo X; Zhu T; Qin J
Clin Microbiol Infect; 2023 Dec; 29(12):1601.e1-1601.e7. PubMed ID: 37652124
[TBL] [Abstract][Full Text] [Related]
40. Isolation and characterisation of lytic bacteriophages of Klebsiella pneumoniae and Klebsiella oxytoca.
Karumidze N; Kusradze Ia; Rigvava S; Goderdzishvili M; Rajakumar K; Alavidze Z
Curr Microbiol; 2013 Mar; 66(3):251-8. PubMed ID: 23143289
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
